Eurofins Transplant Genomics is a brand that aims to enhance kidney transplant outcomes through the use of molecular diagnostic tests. These tests are designed to detect early signs of graft injury, differentiate between actionable causes, and optimize therapy. With a focus on improving post-transplant complications, Eurofins Transplant Genomics recognizes the risks that allograft function poses to patients.

They understand that despite advancements in surgical and medical practices, acute rejection and chronic damage to transplanted organs continue to be significant issues. By offering non-invasive genomic monitoring, Eurofins Transplant Genomics provides healthcare professionals with valuable insights that can improve transplant outcomes. Their commitment to scientific research and development since 2014 has made them a trusted brand in the field of organ transplant diagnostics.

With their range of products and services, they aim to improve the quality of life for transplant patients and contribute to the success of renal and liver transplants